WHO recommends Pfizer's corona pill
The World Health Organization has found that the risk of hospital admission was 85 percent lower for patients treated with the drug.
by ritzau, translated by catherine brett
A pill-based treatment for Covid-19 developed by Pfizer has received a strong recommendation from the World Health Organization (WHO).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Pfizer to acquire Reviral as RSV race continues
For subscribers
.jpg&w=384&q=75)
